Phase III results show rituximab excels against paediatric Burkitt lymphoma
Results of the phase III Inter-B-NHL-ritux 2010 clinical trial reported in the New England Journal of…
Results of the phase III Inter-B-NHL-ritux 2010 clinical trial reported in the New England Journal of…
Researchers at the Francis Crick Institute have uncovered how cancer cells protect themselves from viruses…
Targeting large clones of skin cells caused by ultraviolet irradiation (UV) may help reduce skin…
Researchers at Wake Forest School of Medicine, USA, have discovered that nicotine promotes the spread…
Size and number of fused cancer and immune cells linked to survival in non-small cell…
A new study will enable clinicians to identify patients with aggressive leukaemia who will not…
One of the first studies to investigate the outcome of COVID-19 infection in patients with…
New images of an enzyme in action as it interacts with the chromosome could provide…
The international study “Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific…
By analysing 442 samples from three groups of children and adults with acute myeloid leukaemia…